Cannabis og glaukom

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Cannabis og glaukom. / Mouhammad, Zaynab Ahmad; Kolko, Miriam.

In: Ugeskrift for Laeger, Vol. 180, V11170861, 16.07.2018, p. 2-4.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Mouhammad, ZA & Kolko, M 2018, 'Cannabis og glaukom', Ugeskrift for Laeger, vol. 180, V11170861, pp. 2-4. <http://ugeskriftet.dk/videnskab/cannabis-og-glaukom>

APA

Mouhammad, Z. A., & Kolko, M. (2018). Cannabis og glaukom. Ugeskrift for Laeger, 180, 2-4. [V11170861]. http://ugeskriftet.dk/videnskab/cannabis-og-glaukom

Vancouver

Mouhammad ZA, Kolko M. Cannabis og glaukom. Ugeskrift for Laeger. 2018 Jul 16;180:2-4. V11170861.

Author

Mouhammad, Zaynab Ahmad ; Kolko, Miriam. / Cannabis og glaukom. In: Ugeskrift for Laeger. 2018 ; Vol. 180. pp. 2-4.

Bibtex

@article{69c9c81a75bb420db4e6615176cd628c,
title = "Cannabis og glaukom",
abstract = "Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both ∆-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.",
author = "Mouhammad, {Zaynab Ahmad} and Miriam Kolko",
year = "2018",
month = jul,
day = "16",
language = "Dansk",
volume = "180",
pages = "2--4",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",

}

RIS

TY - JOUR

T1 - Cannabis og glaukom

AU - Mouhammad, Zaynab Ahmad

AU - Kolko, Miriam

PY - 2018/7/16

Y1 - 2018/7/16

N2 - Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both ∆-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.

AB - Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both ∆-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.

M3 - Tidsskriftartikel

C2 - 30020072

VL - 180

SP - 2

EP - 4

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V11170861

ER -

ID: 214264909